Erector Spinae Plane Block in Liver Transplantation Donors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-24

Study Completion Date

2023-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Living donor liver transplantation has become a common treatment option for patients with end-stage liver disease. Donor hepatectomy is associated with significant postoperative pain due to inverted L-shaped incision. Therefore adequate analgesia is important for recovery.

Erector Spinae Plane Block (ESPB) is a safe anesthesia technique used to provide postoperative analgesia. This study aimed to compare the novel ultrasound-guided ESPB technique with controls in terms of postoperative opioid consumption and postoperative pain control on donor patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Erector Spinae Plane Block in Renal Transplantation Donors

NCT04863716

Renal Transplantation Laparoscopic Nephrectomy Erector Spinae Plane Block

COMPLETED NA

Comparison of the Postoperative Analgesic Effects of ITM and Bi-level ESPB in Liver Transplantation Donors

NCT07123740

Liver Transplantation Pain Management

RECRUITING NA

Intraoperative Placement of Superficial Erector Spinae Plane Block; A New Approach in Spine Surgery

NCT05244031

Postoperative Pain Spine Deformity Spine Injury +2 more

COMPLETED NA

Erector Spina Plane Block for Multilevel Major Spinal Surgery

NCT05983393

Pain Post Operative Pain

COMPLETED NA

Ultrasound-Guided Erector Spinae Plane Block in Major Spinal Surgery

NCT07101198

Perioperative Bleeding Opioid Consumption Erector Spinae Plane Block +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

There are two model for this study. The first group is erector spinae plane block group. The second one is control group.

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

The patient and the anesthesiologist who performs postoperative pain evaluation will not know the group.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector Spinae Plane Block

Erector Spinae Plane Block for Postoperative Analgesia

Group Type ACTIVE_COMPARATOR

Erector Spinae Plane Block

Intervention Type PROCEDURE

Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.

Control group

No regional anesthesia technique will be applied to the control group.

Group Type ACTIVE_COMPARATOR

Intravenous fentanyl patient control device

Intervention Type PROCEDURE

Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erector Spinae Plane Block

Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.

Intervention Type PROCEDURE

Intravenous fentanyl patient control device

Intravenous fentanyl patient control device 48-hour fentanyl consumption will be recorded.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Donor patients scheduled for elective hepatectomy in liver transplantation surgery
* ASA I-II
* Patients who are aged between 18-65

Exclusion Criteria

* Patients who do not accept the procedure
* Skin infection at the site of Erector Spina Plan Block area
* Coagulation disorder or using anticoagulant drugs
* Known local anesthetics and opioid allergy
* Severe pulmonary and/or cardiovascular problems
* Substance addiction or known psychiatric or mental problems
* Chronic painkiller usage
* Pregnancy or lactation

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes